related

InnoCare Announces First Patient Dosed in the Global Phase II Clinical Trial of TYK2 Inhibitor Soficitinib for Treatment of Prurigo Nodularis

BEIJING, Nov. 27, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading biopharmaceutical company focusing on the…

1 week ago

Menarini Group Announces New Data on ELZONRIS (tagraxofusp-erzs) to be Presented at the 67th American Society of Hematology Annual Meeting and Exposition

Data spans five abstracts including two oral presentations with important findings for patients living with blastic plasmacytoid dendritic cell neoplasm (BPDCN)BPDCN…

2 weeks ago

LEAD INNOVATION CORPORATION and ECLECTIC LIMITED Announce Strategic Collaboration to Explore SPAC Listing and Cross-Border Business Synergies

New York, Nov. 23, 2025 (GLOBE NEWSWIRE) -- LEAD INNOVATION CORPORATION (“LEIC”), a range of businesses, including home furnishings, lifestyle,…

2 weeks ago

Algernon Closes First Tranche of its Recently Announced Private Placement Financing

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Nov. 14, 2025 (GLOBE…

3 weeks ago

Breakwater Energy Holdings S. r.l. Announces Pricing of Offering of Senior Secured Notes Due 2030

LUXEMBOURG, Nov. 6, 2025 /PRNewswire/ -- Breakwater Energy Holdings S.à r.l. (the "Issuer") today announced that it has priced an…

4 weeks ago

Aon Signs Definitive Agreement to Sell Significant Majority of NFP’s Wealth Business to Madison Dearborn Partners

-       The agreement includes Wealthspire Advisors, Fiducient Advisors, Newport Private Wealth and related platforms -       Transaction reinforces Aon's focus on core…

3 months ago

BioSig Technologies Supplements Clarification on Recent Schedule 14A Filing. Closing of Merger with Streamex Exchange Corporation Not Affected

Proposal No. 1 (The Acquisition Proposal) to be adjourned pending final NASDAQ approval; Company operations, financings and closing of the…

3 months ago

Mineralys Therapeutics Announces Pricing of Upsized $250.0 Million Underwritten Public Offering of Common Stock

September 02, 2025 21:33 ET  | Source: Mineralys Therapeutics, Inc. RADNOR, Pa., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics,…

3 months ago

Cytokinetics Presents New Data Related to Aficamten at the European Society of Cardiology Congress 2025

Additional Data from MAPLE-HCM Shows Aficamten Improves Cardiac Structure and Function Compared to Metoprolol; Simultaneous Publication in the Journal of the American…

3 months ago

Voxtur Announces Financial Results Delay for Q2 2025

August 29, 2025 19:10 ET  | Source: Voxtur Analytics Corp. TORONTO and TAMPA, Fla., Aug. 29, 2025 (GLOBE NEWSWIRE) --…

3 months ago